The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJ Bell Regulatory News (AJB)

Share Price Information for AJ Bell (AJB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 386.50
Bid: 386.50
Ask: 387.50
Change: -16.50 (-4.09%)
Spread: 1.00 (0.259%)
Open: 382.00
High: 390.50
Low: 379.50
Prev. Close: 403.00
AJB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Trading on the London Stock Exchange

12 Dec 2018 08:00

RNS Number : 1339K
AJ Bell PLC
12 December 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA.

 

12 December 2018

AJ Bell plc

 

Admission to Trading on the London Stock Exchange

 

Following the announcement by AJ Bell on 7 December 2018 of the Offer Price of its IPO, AJ Bell today announces its entire ordinary share capital consisting of 407,055,994 Ordinary Shares of £0.000125 each has today been admitted to the Premium Listing segment of the Official List of the FCA and to trading on the London Stock Exchange's Main Market for listed securities under the ticker "AJB".

 

Capitalised terms used in this announcement have the meanings given to them in the Company's Prospectus.

 

ENQUIRIES

 

AJ Bell

 

Shaun Yates,  Head of Investor Relations

+44 (0) 7522 235 898

Charlie Musson,  Head of PR

+44 (0) 7834 499 554

 

 

Instinctif Partners

+44 (0) 207 457 2020

Public relations adviser to AJ Bell

 

Giles Stewart

 

Rachel Cashmore

 

 

 

Numis Securities

+44 (0) 207 260 1000

Sponsor, financial adviser, sole bookrunner and broker to AJ Bell

 

James Taylor

 

Jamie Loughborough

 

Akshman Ori

 

Huw Jeremy

 

 

Important notices

 

This announcement is for informational purposes only and does not purport to be full or complete, nor does it constitute or form part of any invitation or inducement to engage in investment activity, nor does it constitute an offer or invitation to buy any securities, in any jurisdiction including the United States, or a recommendation in respect of buying, holding or selling any securities. The contents of this announcement are not to be construed as legal, financial or tax advice.

 

Neither this announcement nor the information contained herein nor any copy of it is for publication, distribution or release, in whole or in part, directly or indirectly, in or into or from the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

Any securities referred to herein may not be offered or sold, directly or indirectly, in the United States unless registered under the United States Securities Act of 1933 (the "US Securities Act") or offered in a transaction exempt from, or not subject to, the registration requirements of the US Securities Act. Any potential offer and sale of securities referred to herein will not be registered under the US Securities Act or under the applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the securities in the United States.

 

Numis is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company and no one else in connection with Admission. Numis will not regard any other person (whether or not a recipient of this announcement) as its client in relation to Admission and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Numis or for providing any advice in relation to Admission, the contents of this announcement or any transaction or arrangement referred to herein.

Neither Numis nor any of its affiliates accepts any responsibility whatsoever for the contents of this announcement including its accuracy, completeness and verification or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company, the Shares or the Offer, and nothing contained in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future. Accordingly, apart from the responsibilities and liabilities, if any, which may be imposed on Numis by the Financial Services and Markets Act 2000 or the regulatory regime established thereunder, Numis and each of its affiliates disclaim, to the fullest extent permitted by applicable law, all and any liability whether arising in tort, delict, contract or otherwise which they might otherwise be found to have in respect of this announcement or any such statement. No representation or warranty express or implied, is made by Numis or any of its affiliates as to the accuracy, completeness, verification or sufficiency of the information set out in this announcement, and nothing in this announcement will be relied upon as a promise or representation in this respect, whether or not to the past or future.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
LISTBBTTMBBBBAP
Date   Source Headline
3rd Oct 20228:00 amRNSConsultancy Agreement
29th Sep 20224:45 pmRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSBoard Changes
14th Sep 202211:26 amRNSDirector/PDMR Shareholding
9th Sep 20228:20 amRNSDirector/PDMR Shareholding
9th Sep 20228:20 amRNSDirector/PDMR Shareholding
1st Sep 20229:00 amRNSIssue of Ordinary Shares & Total Voting Rights
1st Sep 20229:00 amRNSDirector/PDMR Shareholding
22nd Aug 20225:04 pmRNSNomination Committee changes
15th Aug 20229:01 amRNSDirector/PDMR Shareholding
12th Aug 20228:52 amRNSDirector/PDMR Shareholding
21st Jul 20227:00 amRNSQ3 Trading Update
12th Jul 20221:04 pmRNSDirector/PDMR Shareholding
30th Jun 20228:12 amRNSIssue of Ordinary Shares & Total Voting Rights
24th Jun 20227:00 amRNSBlock listing six monthly return
16th Jun 20224:42 pmRNSDirectorate Change
15th Jun 20222:22 pmRNSDirector/PDMR Shareholding
1st Jun 20229:41 amRNSDirector/PDMR Shareholding
1st Jun 20229:37 amRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSInterim Results
13th May 20221:24 pmRNSDirector/PDMR Shareholding
26th Apr 20228:52 amRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSQ2 Trading Update
20th Apr 20229:08 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:47 amRNSAdmission of Shares & Total Voting Rights
15th Mar 20222:35 pmRNSDirector/PDMR Shareholding
14th Mar 20222:36 pmRNSDirector/PDMR Shareholding
1st Mar 20224:37 pmRNSIssue of Ordinary Shares & Total Voting Rights
16th Feb 20228:58 amRNSDirector/PDMR Shareholding
14th Feb 202210:43 amRNSHolding(s) in Company
14th Feb 202210:22 amRNSDirector/PDMR Shareholding
4th Feb 20224:09 pmRNSDirector/PDMR Shareholding
27th Jan 202211:54 amRNSDirector/PDMR Shareholding
26th Jan 20224:16 pmRNSResult of AGM
21st Jan 20222:14 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSQ1 Trading Update
18th Jan 20222:29 pmRNSDirector/PDMR Shareholding
12th Jan 202211:58 amRNSDirector/PDMR Shareholding
7th Jan 202210:04 amRNSDirector/PDMR Shareholding
7th Jan 202210:02 amRNSDirector/PDMR Shareholding
31st Dec 20217:00 amRNSIssue of Ordinary Shares & Total Voting Rights
24th Dec 20217:00 amRNSBlock Listing Six Monthly Return
17th Dec 20213:47 pmRNSAnnual Report and Notice of AGM
17th Dec 20212:59 pmRNSBoard Changes
14th Dec 20212:50 pmRNSDirector/PDMR Shareholding
13th Dec 20218:35 amRNSDirector/PDMR Shareholding
13th Dec 20218:33 amRNSIssue of Ordinary Shares & Total Voting Rights
8th Dec 20214:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.